Detalles de la búsqueda
1.
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
Scand J Rheumatol
; 48(1): 9-16, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29985080
2.
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.
Pharmacogenomics J
; 16(2): 141-6, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25939484
3.
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA).
Ann Rheum Dis
; 75(9): 1645-53, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489704
4.
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.
Mult Scler Relat Disord
; 77: 104854, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418931
5.
Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis.
Rheumatol Int
; 32(5): 1457-63, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21461857
6.
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
J Neuroimmunol
; 337: 577085, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655423
7.
Disability in progressive MS is associated with T2 lesion changes.
Mult Scler Relat Disord
; 20: 73-77, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29324249
8.
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
Clin Rheumatol
; 36(4): 781-789, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27921185
Resultados
1 -
8
de 8
1
Próxima >
>>